These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18983537)

  • 1. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation.
    Estrada Y; Dong J; Ossowski L
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):66-76. PubMed ID: 18983537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
    Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
    Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration.
    Okada Y; Saika S; Shirai K; Yamanaka O; Kitano A; Wang Z; Yang H; Reinach P
    Ophthalmic Res; 2009; 42(4):185-92. PubMed ID: 19672126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth.
    Aguirre-Ghiso JA; Ossowski L; Rosenbaum SK
    Cancer Res; 2004 Oct; 64(20):7336-45. PubMed ID: 15492254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.
    Satyamoorthy K; Li G; Gerrero MR; Brose MS; Volpe P; Weber BL; Van Belle P; Elder DE; Herlyn M
    Cancer Res; 2003 Feb; 63(4):756-9. PubMed ID: 12591721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis.
    Gao L; Feng Y; Bowers R; Becker-Hapak M; Gardner J; Council L; Linette G; Zhao H; Cornelius LA
    Cancer Res; 2006 Aug; 66(16):7880-8. PubMed ID: 16912161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.
    Ly DP; Corbett SA
    J Surg Res; 2005 Feb; 123(2):200-5. PubMed ID: 15680379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
    Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
    Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional up-regulation of IL-2 production by p38 MAPK inactivation is mediated by increased Erk1/2 activity.
    Kogkopoulou O; Tzakos E; Mavrothalassitis G; Baldari CT; Paliogianni F; Young HA; Thyphronitis G
    J Leukoc Biol; 2006 May; 79(5):1052-60. PubMed ID: 16478922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma.
    Ellerhorst JA; Ekmekcioglu S; Johnson MK; Cooke CP; Johnson MM; Grimm EA
    Oncogene; 2006 Jun; 25(28):3956-62. PubMed ID: 16474847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK and RAF inhibitors for BRAF-mutated cancers.
    Belden S; Flaherty KT
    Expert Rev Mol Med; 2012 Oct; 14():e17. PubMed ID: 23058743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the mitogen-activated protein kinase pathway in malignant melanoma can occur independently of the BRAF T1799A mutation.
    Yazdi AS; Ghoreschi K; Sander CA; Röcken M
    Eur J Dermatol; 2010; 20(5):575-9. PubMed ID: 20605766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells.
    Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y
    Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
    Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
    Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.
    Zhou J; Chen Y; Lang JY; Lu JJ; Ding J
    Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.